Loading clinical trials...
Loading clinical trials...
68Ga-Pentixafor PET/CT in the Diagnosis of Primary Aldosteronism and Pre-postoperative of Superselective Adrenal Artery Embolization
Conditions
Interventions
68Ga-Pentixafor
Locations
1
China
Department of Nuclear Medicine, First Affiliated Hospital of Fujian Medical University
Fuzhou, Fujian, China
Start Date
September 1, 2020
Primary Completion Date
September 1, 2024
Completion Date
September 1, 2024
Last Updated
September 21, 2023
NCT06696326
NCT05610098
NCT06188468
NCT06558357
NCT05490264
NCT05140083
Lead Sponsor
First Affiliated Hospital of Fujian Medical University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions